Among cancer survivors, excess body weight is associated with an increased risk for a second primary malignant neoplasm, ...

Celiac disease presents a higher risk for developing malignant neoplasms, including small intestine, lymphoma, and skin ...

Foundation Medicine was awarded its 2nd consecutive, 5-year contract by the U.S. Department of Veterans Affairs to provide tumor molecular profiling.

Cetuximab biosimilar is under clinical development by Alkem Laboratories and currently in Phase III for Pharyngeal Neoplasm.

研究结果显示，脑恶性肿瘤（Malignant Neoplasm of the Brain）随着手机使用时间、累计通话时间或累计通话次数的增加， 风险并未明显增加 ；无绳电话的使用与脑胶质瘤、脑膜瘤或听神经瘤的风险 无显著相关性 ...

CHICAGO -- The non-hormonal drug elinzanetant reduced the frequency of moderate-to-severe hot flashes in postmenopausal women ...

Background: Malignant perivascular epitheliod cell tumor ... for melanocytic and muscle markers. At present this neoplasm does not have a known normal cellular counterpart and the natural history ...

Researchers sought to assess the reporting of patient-reported outcomes in associated clinical trial publications.

Jaxx Reasoner’s cancer journey began when he was 5 years old when he was first diagnosed with B-cell acute lymphoblastic ...

Targeting two receptors instead of the one targeted by fezolinetant, the new elinzanetant did not show the liver safety ...

In contrast to intraductal papillary neoplasms, which are much more common ... Accurately assessing the risk of malignant transformation remains challenging because of our limited understanding ...